The North America intravenous catheters market size is expected to reach US$ 14,236.0 million by 2033 from US$ 6,374.1 million in 2024. The market is estimated to record a CAGR of 9.6% from 2025 to 2033.
The intravenous catheters market in North America is experiencing significant growth driven by the increase in hospitalization and surgical procedures; especially in ICUs and oncology, higher adoption of peripherally inserted central catheters (PICCs) and midline catheters, and rising focus on infection control driving demand for coated/antimicrobial catheters. The North American intravenous catheters market is defined by advanced healthcare infrastructure, strong regulatory oversight, and high patient volumes. Peripheral catheters dominate due to their role in routine IV therapy and emergency care, particularly in large hospital networks. Coated catheters are increasingly adopted as infection prevention becomes a priority, with U.S. hospitals aligning with CDC guidelines. Multi‑lumen catheters are widely used in oncology and intensive care, reflecting the region’s focus on complex therapies. Hospitals and clinics remain the largest end‑users, supported by reimbursement frameworks and private sector expansion. Competitive dynamics highlight the dominance of multinational corporations such as BD, Teleflex, and Medtronic, alongside specialized suppliers. Urban centers in the U.S. show strong uptake of advanced coated catheters, while Canada emphasizes accessibility and affordability. Overall, the market reflects a balance of innovation, regulation, and patient safety, positioning North America as a mature yet evolving region for intravenous catheter manufacturers.
North America Intravenous Catheters Market Strategic Insights
Key segments that contributed to the derivation of the intravenous catheters market analysis are product, coating type, lumen, and end user.
The North America intravenous catheters market is segmented into the United States, Canada, and Mexico. The outlook for the North American intravenous catheters market is highly positive, driven by demographic shifts, healthcare reforms, and rising awareness of infection control. Aging populations in the United States and Canada will increase demand for intravenous therapies, while the growing burden of chronic diseases such as diabetes and cancer will further accelerate catheter utilization. Coated catheters are expected to see faster adoption as hospitals prioritize patient safety and align with international infection‑control standards. Multi‑lumen catheters will gain importance in tertiary hospitals, where complex therapies require efficiency and precision. Strategic opportunities lie in expanding catheter use in outpatient and ambulatory care centers, supported by government initiatives to decentralize healthcare delivery. Partnerships with NGOs and global health organizations will also play a role in improving access to intravenous devices in underserved regions. From a business perspective, companies must balance innovation with affordability, tailoring portfolios to meet diverse needs across North American markets. Localization of manufacturing and distribution will be critical to overcoming supply chain challenges, while training programs for healthcare professionals will ensure proper catheter usage and reduce complications. The long‑term outlook positions North America as a growth frontier where companies that invest in education, affordability, and infrastructure partnerships will secure competitive advantage.
Based on region, the North America intravenous catheters market is further segmented into the United States, Canada, and Mexico. The united states held the largest share in 2024.
Country‑level dynamics in North America reveal diverse adoption patterns shaped by healthcare infrastructure, government priorities, and private sector participation. The United States leads the region, supported by advanced hospitals and strong private healthcare investment, driving demand for coated and multi‑lumen catheters in intensive care units. Canada represents a high‑potential market, where affordability and distribution efficiency are critical success factors, as intravenous therapy is widely used in both urban and rural hospitals. Mexico emphasizes modernization, with government programs expanding catheterization labs and infection‑control initiatives, boosting demand for coated catheters. Hospitals and clinics remain the dominant end‑users, but private diagnostic centers are increasingly investing in intravenous catheter technologies to expand service offerings. The diversity of country insights underscores the need for differentiated strategies: premium positioning in the United States and Canada, affordability in Mexico, and partnership‑driven expansion in emerging economies. Collectively, North America’s country‑level dynamics highlight a patchwork of opportunities where localized approaches, strong distribution networks, and education initiatives are essential for sustained success.
North America Intravenous Catheters Market Report Highlights| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 6,374.1 Million |
| Market Size by 2033 | US$ 14,236.0 Million |
| CAGR (2025 - 2033) | 9.6% |
| Historical Data | 2022-2023 |
| Forecast period | 2025-2033 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| North America | United States, Canada, Mexico |
| Market leaders and key company profiles |
|
Mediplus India Ltd, Boston Scientific Corp, Becton Dickinson and Co, Teleflex Inc, B Braun SE, Sterimed Medical Devices Pvt Ltd, Terumo Corp, Angiplast, Cook Medical Holdings LLC, ICU Medical Inc, are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The North America Intravenous Catheters Market is valued at US$ 6,374.1 Million in 2024, it is projected to reach US$ 14,236.0 Million by 2033.
As per our report North America Intravenous Catheters Market, the market size is valued at US$ 6,374.1 Million in 2024, projecting it to reach US$ 14,236.0 Million by 2033. This translates to a CAGR of approximately 9.6% during the forecast period.
The North America Intravenous Catheters Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Intravenous Catheters Market report:
The North America Intravenous Catheters Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Intravenous Catheters Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Intravenous Catheters Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)